Latest Breaking News On - Mendus - Page 1 : comparemela.com

Mendus And Australasian Leukaemia & Lymphoma Group To Expand Clinical Testing Of Vididencel As Maintenance Treatment For AML

Mendus receives ATMP certificate from European Medicines Agency supporting its lead pipeline program vididencel

POSITIVE RECOMMENDATION BY COMMITTEE FOR ADVANCED THERAPIES CONFIRMS QUALITY OF THE MANUFACTURING PROCESS AND PRECLINICAL DATA SUBMITTED Mendus AB , a biopharmaceutical company focused on. | June 19, 2023

Mendus : Item 8. The board of directors complete proposal on approval of directed issue

The board of directors of Mendus AB , reg. no 556629-1786, complete proposal for resolution on approval of directed issue of shares and warrants . | June 9, 2023

Mendus : The board of directors resolution on directed issue

The board of directors of Mendus AB , reg. no 556629-1786, resolution on directed issue of shares and warrants . | June 9, 2023

Mendus : Item 7. The board of directors complete proposal on approval of rights issue

The board of directors of Mendus AB , reg. no 556629-1786, complete proposal for resolution on approval of issue of shares and warrants with preferential rights for existing. | June 9, 2023